Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
Arvin Medhat, Alla Arzumanyan, Mark A. Feitelson
Oncotarget (2021) Vol. 12, Iss. 24, pp. 2421-2433
Open Access | Times Cited: 19

Showing 19 citing articles:

Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
Anja Schollmeier, Mirco Glitscher, Eberhard Hildt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4964-4964
Open Access | Times Cited: 34
Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis
Hongjuan You, Ning Zhang, Tong Yu, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 6, pp. 992-1004
Open Access | Times Cited: 16
Applications of cell therapy in the treatment of virus-associated cancers
Keri Toner, Chase D. McCann, Catherine M. Bollard
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 10, pp. 709-724
Closed Access | Times Cited: 4
Evaluation of antiviral potential of Cinchona officinalis derived compounds against COVID-19 and Human hepatitis B: An in silico Molecular Docking and Molecular Dynamics Simulation study
Emmanuel Kitete Mulongo, Aristote Matondo, Koto-te-Nyiwa Ngbolua, et al.
Pharmacological Research - Natural Products (2025), pp. 100229-100229
Closed Access
Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection
Hongjuan You, Suping Qin, Fulong Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
A decade of liver organoids: Advances in disease modeling
Yue Liu, Jian-Ying Sheng, Chunfang Yang, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 643-669
Open Access | Times Cited: 10
Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis
Hongjuan You, Qi Li, Lihong Ma, et al.
Journal of Molecular Cell Biology (2024) Vol. 16, Iss. 4
Open Access | Times Cited: 3
EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
Chen-Shiou Wu, Yi‐Chung Chien, Chia‐Jui Yen, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential
John Bacher, Lena Allweiss, Maura Dandri
Viruses (2024) Vol. 16, Iss. 11, pp. 1667-1667
Open Access | Times Cited: 3
Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
Mark A. Feitelson, Alla Arzumanyan, Ira J. Spector, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2210-2210
Open Access | Times Cited: 13
Histomolecular characterisation of hepatitis B virus induced liver cancer
Adane Adugna
Reviews in Medical Virology (2023) Vol. 33, Iss. 6
Open Access | Times Cited: 7
Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma
Qingqing Dai, Quratul Ain, Michael Rooney, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein
Xiaocui Li, Delong Kong, Wei Hu, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, et al.
Annals of Hepatology (2024) Vol. 30, Iss. 1, pp. 101533-101533
Closed Access | Times Cited: 1
Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis
Yaqun Li, Jianhua Li, Tianye He, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2331-2331
Open Access | Times Cited: 7
In silico molecular study of hepatitis B virus X protein as a therapeutic target
Yassir Hamadalnil, Hisham N. Altayb
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 4002-4015
Closed Access | Times Cited: 3
HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
Chiyumi Oda, Kenya Kamimura, Osamu Shibata, et al.
Biochemistry and Biophysics Reports (2022) Vol. 32, pp. 101352-101352
Open Access | Times Cited: 4
EZH2-mediated epigenetic silencing of tumor- suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
Chen-Shiou Wu, Yi‐Chung Chien, Chia‐Jui Yen, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma
Bin Wang, li yaqun, Furan Wang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top